​​​​​​​Researchers recently reported positive 12-month data for the DETOUR I Trial, which assessed the PQ Bypass DETOUR System for percutaneous bypass. | Read More

A new study examined national trends in admissions, invasive treatments, and inpatient mortality of patients with thoracic aortic aneurysm and type B dissection. | Read More

Two-year results from the IN.PACT Global Study were recently published in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions. | Read More

TEVAR has been increasingly used for type B aortic dissection, but there have not been large amounts of data available on outcomes for complicated cTBD. | Read More

The FDA has approved the IN.PACT Admiral drug-coated balloon for an expanded indication to treat long SFA lesions. | Read More

The results of the landmark study were reported at Charing Cross 2018 and simultaneously published in the New England Journal of Medicine. | Read More

Forge Medical, a U.S. developer of innovative solutions for transradial and transpedal hemostasis and manufacturer of the VasoStat® Hemostasis Device, announced that the company has entered into a commercialization agreement with Lokai Medical. | Read More

The FDA has approved an expanded indication of the Gore Cardioform Septal Occluder. | Read More

The association between time to endovascular treatment and functional outcome in patients with acute ischemic stroke may be stronger than previously suggested. | Read More

The FDA has approved an expanded indication of the Vascade Vascular Closure System, according to an announcement by Cardiva Medical. | Read More